| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print June 28, 2007
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the Department of Pathology,* McMaster University, Hamilton, Ontario, Canada; the Clinical Experimental Center,
the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; and the Department of Gastroenterology,
the Second Hospital, Zhengzhou University, Zhengzhou, China
Bacterium-induced diarrhea results in 2 to 2.5 million deaths in the world each year. The mechanism needs to be further understood. Staphylococcus aureus infection has a close relation with diarrhea; its cell wall component peptidoglycan (PGN) has strong biological activity on immune cells and possibly plays a role in S. aureus-induced diarrhea. The present study showed that oral PGN-induced diarrhea in mice in a dose-dependent manner. Intestinal epithelial cells absorbed PGN via the intracellular pathway. Intestinal mast cells were activated after PGN gavage. Toll-like receptor (TLR)2 expression was detected in mast cells in the intestine as well as in the murine mast cell line p815 cells. Blocking TLR2 or nucleotide-binding oligomerization domain (NOD)1 with related antibodies or RNA interference abolished PGN-induced p815 cell activation. The mast cell mediator histamine and serotonin had synergistic effects in PGN-induced diarrhea. In summary, oral PGN can induce diarrhea in mice, and TLR2 and NOD1 mediate the PGN-induced mast cell activation that plays a critical role in diarrhea induction. Blockade of TLR2 or NOD1 or treating mice with a mast cell stabilizer can efficiently inhibit PGN-induced-diarrhea, providing potential therapeutic significance.
This article has been cited by other articles:
![]() |
E. Ronnberg, B. Guss, and G. Pejler Infection of Mast Cells with Live Streptococci Causes a Toll-Like Receptor 2- and Cell-Cell Contact-Dependent Cytokine and Chemokine Response Infect. Immun., February 1, 2010; 78(2): 854 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, B.-S. Feng, P.-Y. Zheng, X.-Q. Liao, J. Chong, S.-G. Tang, and P.-C. Yang Fc Gamma Receptor Signaling in Mast Cells Links Microbial Stimulation to Mucosal Immune Inflammation in the Intestine Am. J. Pathol., December 1, 2008; 173(6): 1647 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rocha-de-Souza, B. Berent-Maoz, D. Mankuta, A. E. Moses, and F. Levi-Schaffer Human Mast Cell Activation by Staphylococcus aureus: Interleukin-8 and Tumor Necrosis Factor Alpha Release and the Role of Toll-Like Receptor 2 and CD48 Molecules Infect. Immun., October 1, 2008; 76(10): 4489 - 4497. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nitta, T. Imamura, Y. Wada, A. Irie, H. Kobayashi, K. Okamoto, and H. Baba Production of C5a by ASP, a Serine Protease Released from Aeromonas sobria J. Immunol., September 1, 2008; 181(5): 3602 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sherman The Role of Mast Cells in Bacterial Enteritis Am. J. Pathol., August 1, 2007; 171(2): 399 - 401. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |